-
Je něco špatně v tomto záznamu ?
CD49b defines functionally mature Treg cells that survey skin and vascular tissues
X. Fan, B. Moltedo, A. Mendoza, AN. Davydov, MB. Faire, L. Mazutis, R. Sharma, D. Pe'er, DM. Chudakov, AY. Rudensky,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
F30 AI122721
NIAID NIH HHS - United States
P30 CA008748
NCI NIH HHS - United States
R37 AI034206
NIAID NIH HHS - United States
T32 GM007739
NIGMS NIH HHS - United States
Howard Hughes Medical Institute - United States
NLK
Free Medical Journals
od 1896 do Před 6 měsíci
Europe PubMed Central
od 1896 do Před 6 měsíci
Open Access Digital Library
od 1896-01-01
Open Access Digital Library
od 1896-01-01
Open Access Digital Library
od 1996-01-01
PubMed
30355617
DOI
10.1084/jem.20181442
Knihovny.cz E-zdroje
- MeSH
- cévy imunologie MeSH
- imunitní dozor * MeSH
- integrin alfa2 genetika imunologie MeSH
- kůže krevní zásobení cytologie imunologie MeSH
- lymfatické uzliny krevní zásobení cytologie imunologie MeSH
- myši transgenní MeSH
- myši MeSH
- regulační T-lymfocyty cytologie imunologie MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
Regulatory T (Treg) cells prevent autoimmunity by limiting immune responses and inflammation in the secondary lymphoid organs and nonlymphoid tissues. While unique subsets of Treg cells have been described in some nonlymphoid tissues, their relationship to Treg cells in secondary lymphoid organs and circulation remains unclear. Furthermore, it is possible that Treg cells from similar tissue types share largely similar properties. We have identified a short-lived effector Treg cell subset that expresses the α2 integrin, CD49b, and exhibits a unique tissue distribution, being abundant in peripheral blood, vasculature, skin, and skin-draining lymph nodes, but uncommon in the intestines and in viscera-draining lymph nodes. CD49b+ Treg cells, which display superior functionality revealed by in vitro and in vivo assays, appear to develop after multiple rounds of cell division and TCR-dependent activation. Accordingly, single-cell RNA-seq analysis placed these cells at the apex of the Treg developmental trajectory. These results shed light on the identity and development of a functionally potent subset of mature effector Treg cells that recirculate through and survey peripheral tissues.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19034946
- 003
- CZ-PrNML
- 005
- 20191015114116.0
- 007
- ta
- 008
- 191007s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1084/jem.20181442 $2 doi
- 035 __
- $a (PubMed)30355617
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Fan, Xiying $u Howard Hughes Medical Institute, Immunology Program, and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY.
- 245 10
- $a CD49b defines functionally mature Treg cells that survey skin and vascular tissues / $c X. Fan, B. Moltedo, A. Mendoza, AN. Davydov, MB. Faire, L. Mazutis, R. Sharma, D. Pe'er, DM. Chudakov, AY. Rudensky,
- 520 9_
- $a Regulatory T (Treg) cells prevent autoimmunity by limiting immune responses and inflammation in the secondary lymphoid organs and nonlymphoid tissues. While unique subsets of Treg cells have been described in some nonlymphoid tissues, their relationship to Treg cells in secondary lymphoid organs and circulation remains unclear. Furthermore, it is possible that Treg cells from similar tissue types share largely similar properties. We have identified a short-lived effector Treg cell subset that expresses the α2 integrin, CD49b, and exhibits a unique tissue distribution, being abundant in peripheral blood, vasculature, skin, and skin-draining lymph nodes, but uncommon in the intestines and in viscera-draining lymph nodes. CD49b+ Treg cells, which display superior functionality revealed by in vitro and in vivo assays, appear to develop after multiple rounds of cell division and TCR-dependent activation. Accordingly, single-cell RNA-seq analysis placed these cells at the apex of the Treg developmental trajectory. These results shed light on the identity and development of a functionally potent subset of mature effector Treg cells that recirculate through and survey peripheral tissues.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a cévy $x imunologie $7 D001808
- 650 12
- $a imunitní dozor $7 D007157
- 650 _2
- $a integrin alfa2 $x genetika $x imunologie $7 D039421
- 650 _2
- $a lymfatické uzliny $x krevní zásobení $x cytologie $x imunologie $7 D008198
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši transgenní $7 D008822
- 650 _2
- $a kůže $x krevní zásobení $x cytologie $x imunologie $7 D012867
- 650 _2
- $a regulační T-lymfocyty $x cytologie $x imunologie $7 D050378
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Moltedo, Bruno $u Howard Hughes Medical Institute, Immunology Program, and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY.
- 700 1_
- $a Mendoza, Alejandra $u Howard Hughes Medical Institute, Immunology Program, and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY.
- 700 1_
- $a Davydov, Alexey N $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Faire, Mehlika B $u Howard Hughes Medical Institute, Immunology Program, and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY.
- 700 1_
- $a Mazutis, Linas $u Single Cell Research Initiative, Memorial Sloan Kettering Cancer Center, New York, NY. Program for Computational and Systems Biology, Memorial Sloan Kettering Cancer Center, New York, NY.
- 700 1_
- $a Sharma, Roshan $u Program for Computational and Systems Biology, Memorial Sloan Kettering Cancer Center, New York, NY. Department of Applied Physics and Applied Mathematics, Columbia University, New York, NY.
- 700 1_
- $a Pe'er, Dana $u Single Cell Research Initiative, Memorial Sloan Kettering Cancer Center, New York, NY. Program for Computational and Systems Biology, Memorial Sloan Kettering Cancer Center, New York, NY.
- 700 1_
- $a Chudakov, Dmitriy M $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic. Privolzhsky Research Medical University, Nizhny Novgorod, Russia. Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia. Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia.
- 700 1_
- $a Rudensky, Alexander Y $u Howard Hughes Medical Institute, Immunology Program, and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY rudenska@mskcc.org.
- 773 0_
- $w MED00002668 $t The Journal of experimental medicine $x 1540-9538 $g Roč. 215, č. 11 (2018), s. 2796-2814
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30355617 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191015114542 $b ABA008
- 999 __
- $a ok $b bmc $g 1451606 $s 1073496
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 215 $c 11 $d 2796-2814 $e 20181024 $i 1540-9538 $m The Journal of experimental medicine $n J Exp Med $x MED00002668
- GRA __
- $a F30 AI122721 $p NIAID NIH HHS $2 United States
- GRA __
- $a P30 CA008748 $p NCI NIH HHS $2 United States
- GRA __
- $a R37 AI034206 $p NIAID NIH HHS $2 United States
- GRA __
- $a T32 GM007739 $p NIGMS NIH HHS $2 United States
- GRA __
- $p Howard Hughes Medical Institute $2 United States
- LZP __
- $a Pubmed-20191007
